India to Azerbaijan Pharmaceutical Export (2026) — $4.3M, 60 Suppliers | TransData Nexus

India to Azerbaijan Pharmaceutical Export (2026) — $4.3M, 60 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Azerbaijan

#	Formulation	Value	Share
1	Enoksan-40 - 40 Mg/0.4 ML	$188.3K	4.3%
2	Bola Tablets N100	$143.3K	3.3%
3	Vaccine for Human Medicine	$140.3K	3.2%
4	Lopinavir 200mg + Ritonavir 50mg Tablets (120's) (7000pack X 120 )	$110.3K	2.5%
5	Levostin -(levofloxacin 10% W/v and Colistin Sulphate 1.5% W/v Oral Liquid)-100…	$90.4K	2.1%
6	Nizacard Ranolazine Tablet	$83.6K	1.9%
7	Dolutegravir 50mg Tablet 30s	$80.2K	1.8%
8	Isoflurane 250ml Desc.as Per Invoice Attch.green Card No.420/vsez Dt.10/05/2009	$73.9K	1.7%
9	Isoflurane 100ml Desc.as Per Invoice Attch.green Card No.420/vsez Dt.10/05/2009	$72.6K	1.7%
10	Vaxirab N Injection [1x1vial]	$65.7K	1.5%
11	Pharmaceutical Finished Formulation: Omeez-mega ,10x10 Capsules	$64.1K	1.5%
12	Empa-lina Tablets Empa.linagliptin Tablets	$62.4K	1.4%
13	Harmless Life Saving Pharmaceutical Medicine Metaglif (3x10 Tablets Per Pack) D…	$50.6K	1.2%
14	Tetanus Vaccine 1 Dose Vaccine for Human Medicine	$49.8K	1.1%
15	Lopinavir 200mg + Ritonavir 50mg Tablets	$48.0K	1.1%

India exports 20+ pharmaceutical formulations to Azerbaijan with a combined trade value of $4.3M. Key products include Vaccine ($140K), Ritonavir ($110K), Levofloxacin ($90K), Dolutegravir ($80K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 571 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Azerbaijan Trade Routes

1Vaccine$140K

2Ritonavir$110K

3Levofloxacin$90K

4Dolutegravir$80K

These are the top pharmaceutical products exported from India to Azerbaijan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Azerbaijan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Vaccine ($140K), Ritonavir ($110K), Levofloxacin ($90K), Dolutegravir ($80K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Azerbaijan

1Hindaz Corporation Llp

$568K

2Opes Health Care Private Limited

$531K

3Acies Pharmaceutical Private Limited

$290K

4Serum Institute Of India Private Limited

$266K

5Hetero Labs Limited

Port Analysis — India to Azerbaijan Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)24.9%

SAHAR AIR CARGO ACC (INBOM4)10.7%

AHEMDABAD ICD (INSBI6)7.0%

HYDERABAD ACC (INHYD4)1.9%

DELHI AIR CARGO ACC (INDEL4)15.1%

Azerbaijan Import Ports

BAKU52.5%

Baku27.5%

HEYDAR ALIYEV ARPT11.0%

Poti7.7%

Trade Statistics

Total Value$4.3M

Shipments571

Indian Exporters60

Azerbaijan Buyers71

Avg Shipment$8K

Products445

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

Market Opportunity Assessment — Azerbaijan for Indian Pharma

Market size, healthcare system, growth outlook

1Market Size & Growth

Azerbaijan's pharmaceutical market has been experiencing steady growth, with the Prescription Drugs segment projected to reach a revenue of approximately $164.57 million AZN in 2025, and an anticipated compound annual growth rate (CAGR) of 4.31% from 2025 to 2029, leading to a market volume of around $194.84 million AZN by 2029. This growth is driven by factors such as an aging population and an increasing prevalence of chronic diseases, which elevate the demand for pharmaceutical products.

The market remains heavily import-dependent, with a significant portion of pharmaceutical products sourced from abroad. However, Azerbaijan is actively working to reduce this dependency by enhancing domestic production capabilities. Initiatives include the establishment of pharmaceutical manufacturing facilities within the Pirallahi Industrial Park and plans for a pharmaceutical cluster in the Alat Free Economic Zone, attracting investments from countries like Israel, Turkey, and Pakistan. (caliber.az) Despite these efforts, the share of generic drugs in the market is substantial, as consumers often prefer generics due to their affordability.

2Healthcare System

Azerbaijan's healthcare system underwent significant reforms with the full implementation of mandatory health insurance in April 2021. This system covers primary, inpatient, emergency, and specialized outpatient care, as well as laboratory services, physiotherapy, and invasive radiology. The State Agency for Mandatory Health Insurance (SAMHI) oversees the system, while the Administration of the Regional Medical Divisions (TABIB) is responsible for providing health services. In May 2025, Azerbaijan moved to include outpatient drug coverage under the mandatory health insurance system, aiming to ensure continuous access to medications, especially for chronic and widespread diseases. (trend.az)

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Azerbaijan

Competing origins, India's edge, challenges and threats

1Competing Origins

Azerbaijan's pharmaceutical market is supplied by a diverse array of countries, including China, European Union (EU) manufacturers, domestic producers, and other emerging markets. China and EU countries have established a significant presence in Azerbaijan's pharmaceutical sector. For instance, in 2024, Turkey exported pharmaceutical products worth $48.44 million to Azerbaijan, indicating a strong foothold in the market. Hungary also plays a notable role, with nearly 49% of its exports to Azerbaijan in 2024 being pharmaceutical products. (trend.az) Domestic production in Azerbaijan is on the rise, with initiatives aimed at reducing dependence on imports and fostering local manufacturing capabilities. (caliber.az) Other emerging markets, such as Pakistan, have also contributed to Azerbaijan's pharmaceutical imports, with exports valued at $879.91 thousand in 2024. While specific market share data is limited, these figures highlight the competitive landscape and the presence of multiple suppliers in Azerbaijan's pharmaceutical market.

2India's Competitive Edge

India's pharmaceutical industry offers several competitive advantages in the Azerbaijani market. The country's cost competitiveness is evident, with India's pharmaceutical exports to Azerbaijan valued at $4.3 million in 2022, encompassing 571 shipments from 60 exporters. This suggests a broad range of affordable products catering to various segments of the market. India's adherence to WHO-GMP standards ensures high-quality manufacturing processes, enhancing the reliability of its pharmaceutical products. The widespread use of English among Indian professionals facilitates effective communication and collaboration with Azerbaijani partners. Additionally, India's extensive portfolio, including vaccines, generics, and specialized formulations, provides Azerbaijani consumers with a diverse selection of pharmaceutical options.

3Challenges & Threats

Despite its strengths, India faces several challenges in the Azerbaijani pharmaceutical market. Regulatory tightening in Azerbaijan, such as the requirement for WHO-GMP certification by the National Drug Regulatory Authority, may pose compliance challenges for Indian exporters. Intensifying competition from countries like China and Turkey, which have established strong market presences, could impact India's market share. Additionally, perceptions regarding the quality of Indian pharmaceuticals may affect consumer preferences, necessitating ongoing efforts to build trust and demonstrate product efficacy.

TransData Nexus Research · Global trade databasesMar 2026

FAQ — India to Azerbaijan Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Azerbaijan?

India exported pharmaceuticals worth $4.3M to Azerbaijan across 571 verified shipments.

Who are the top Indian pharmaceutical exporters to Azerbaijan?

1. HINDAZ CORPORATION LLP — $567.7K. 2. OPES HEALTH CARE PRIVATE LIMITED — $531.0K. 3. ACIES PHARMACEUTICAL PRIVATE LIMITED — $290.3K. Total: 60 suppliers.

Which companies in Azerbaijan import pharmaceuticals from India?

1. LITPHARM LLC — $427.1K. 2. ZEYTUN PHARMACEUTICALS LLC — $326.2K. 3. TO THE ORDER. — $315.4K. 71 buyers total.

What pharmaceutical products does India export most to Azerbaijan?

1. Enoksan-40 - 40 Mg/0.4 ML ($188.3K, 4.3%); 2. Bola Tablets N100 ($143.3K, 3.3%); 3. Vaccine for Human Medicine ($140.3K, 3.2%); 4. Lopinavir 200mg + Ritonavir 50mg Tablets (120's) (7000pack X 120 ) ($110.3K, 2.5%); 5. Levostin -(levofloxacin 10% W/v and Colistin Sulphate 1.5% W/v Oral Liquid)-100… ($90.4K, 2.1%)

Which ports handle pharmaceutical shipments from India to Azerbaijan?

Export: NHAVA SHEVA SEA (INNSA1), SAHAR AIR CARGO ACC (INBOM4), AHEMDABAD ICD (INSBI6), HYDERABAD ACC (INHYD4), DELHI AIR CARGO ACC (INDEL4). Import: BAKU, Baku, HEYDAR ALIYEV ARPT, Poti.

Why does Azerbaijan import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $4.3M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Azerbaijan?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Azerbaijan pharmaceutical trade?

$7.6K per consignment across 571 shipments.

How many Indian pharmaceutical companies export to Azerbaijan?

60 Indian companies. Largest: HINDAZ CORPORATION LLP with $567.7K.

How can I find verified Indian pharmaceutical suppliers for Azerbaijan?

TransData Nexus covers 60 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Azerbaijan identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 571 verified shipments from 60 Indian exporters to 71 Azerbaijan buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

60 Exporters

71 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Azerbaijan Pharmaceutical Export